A randomized controlled trial of an adapted Illness Management and Recovery program for people with schizophrenia awaiting discharge from a psychiatric hospital.

2013 ◽  
Vol 36 (4) ◽  
pp. 243-249 ◽  
Author(s):  
Esther Ching-Lan Lin ◽  
Chin Hong Chan ◽  
Wen-Chuan Shao ◽  
Mei-Feng Lin ◽  
Shujen Shiau ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Psychiatric Hospital ◽  
Controlled Trial ◽  
Illness Management ◽  
Illness Management And Recovery ◽  
Randomized Controlled ◽  
Recovery Program

Randomized Controlled Trial of Illness Management and Recovery in Multiple-Unit Supportive Housing

2009 ◽  
Vol 60 (12) ◽  
pp. 1629-1636 ◽  
Author(s):  
Aaron J. Levitt ◽  
Kim T. Mueser ◽  
Joe DeGenova ◽  
Julie Lorenzo ◽  
Dawn Bradford-Watt ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Supportive Housing ◽  
Illness Management ◽  
Illness Management And Recovery ◽  
Randomized Controlled ◽  
Multiple Unit

scholarly journals Effects of Illness Management and Recovery: A Multicenter Randomized Controlled Trial

2021 ◽  
Vol 12 ◽  
Author(s):  
Bert-Jan Roosenschoon ◽  
Jaap van Weeghel ◽  
Mathijs L. Deen ◽  
Emmie W. van Esveld ◽  
Astrid M. Kamperman ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Primary Outcome ◽  
Controlled Trial ◽  
Self Esteem ◽  
Group Differences ◽  
Illness Management ◽  
Personal Recovery ◽  
Illness Management And Recovery ◽  
Randomized Controlled ◽  
The Impact

There have been inconsistent findings in the literature with respect to the efficacy of Illness Management and Recovery (IMR) in the psychosocial treatment of people with schizophrenia or other severe mental illnesses. This study aimed to comprehensively investigate the effectiveness of IMR, including the impact of completion and fidelity. In this randomized controlled trial (RCT), 187 outpatients received either IMR plus care as usual (CAU) or only CAU. Multilevel modeling was implemented to investigate group differences over an 18-month period, comprising 12 months of treatment and six months of follow-up. The primary outcome was overall illness management, which was assessed using the client version of the IMR scale. Secondary outcomes included measures regarding illness management, clinical, personal, and functional recovery, and hospitalizations. The interviewers were blinded to group allocation. This clinical trial was registered with the Netherlands Trial Register (NL4931, NTR5033). Patients who received IMR showed statistically significant improvement in self-reported overall illness management (the primary outcome). Moreover, they showed an improvement in self-esteem, which is a component of personal recovery. There were no effects within the other questionnaires. There were also no statistically significant between-group differences in terms of hospitalizations. Patients in both groups showed statistically significant improvement in clinician-rated overall illness management, social support, clinical and functional recovery, and self-stigma over time. IMR completion was associated with stronger effects. High IMR fidelity was associated with self-esteem. This study confirms the efficacy of IMR in overall illness self-management. To our knowledge, this is the first RCT on IMR to explore the impact of fidelity on treatment efficacy. Future studies should further establish efficacy in personal recovery. To improve efficacy, it appears important to promote IMR completion and fidelity.

scholarly journals A Randomized Controlled Trial of Illness Management and Recovery With an Active Control Group

2014 ◽  
Vol 65 (8) ◽  
pp. 1005-1011 ◽  
Author(s):  
Michelle P. Salyers ◽  
Alan B. McGuire ◽  
Marina Kukla ◽  
Sadaaki Fukui ◽  
Paul H. Lysaker ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Active Control ◽  
Controlled Trial ◽  
Control Group ◽  
Illness Management ◽  
Active Control Group ◽  
Illness Management And Recovery ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document